Rogers, J., Eudy, A., Alexander, R., Pisetsky, D., Conklin, J., Sun, K., … Clowse, M. (2022). The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE. In ARTHRITIS & RHEUMATOLOGY (Vol. 74, pp. 4159–4161).

Rogers, Jennifer, Amanda Eudy, Roberta Alexander, David Pisetsky, John Conklin, Kai Sun, Lisa Criscione-Schreiber, et al. “The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE.” In ARTHRITIS & RHEUMATOLOGY, 74:4159–61, 2022.

Rogers J, Eudy A, Alexander R, Pisetsky D, Conklin J, Sun K, et al. The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE. In: ARTHRITIS & RHEUMATOLOGY. 2022. p. 4159–61.

Rogers, Jennifer, et al. “The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE.” ARTHRITIS & RHEUMATOLOGY, vol. 74, 2022, pp. 4159–61.

Rogers J, Eudy A, Alexander R, Pisetsky D, Conklin J, Sun K, Criscione-Schreiber L, Doss J, Sadun R, Maheswaranathan M, Clowse M. The Use of Cell-bound Complement Activation Product to Assess Disease Activity in SLE. ARTHRITIS & RHEUMATOLOGY. 2022. p. 4159–4161.